0 NASDAQ Companies - January 10, 2025Rail Vision Receives Purchase Order from One of the Leading Central America Freight Rail OperatorsRa’anana, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the […]Read More
0 NYSE Companies - January 10, 2025High Roller Technologies Welcomes Kristofer Muscat as Chief Operating OfficerLas Vegas, Nevada, Jan. 10, 2025 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller” and the “Company”) (NYSE American: […]Read More
0 NASDAQ Companies - January 10, 2025NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple CancersBELTSVILLE, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]Read More
0 NASDAQ Companies - January 10, 2025BTCS Launches Innovative Staker Protection PlanSilver Spring, MD, Jan. 10, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in […]Read More
0 NASDAQ Companies - January 10, 2025OrthoPediatrics Corp. Announces Expansion of Specialty Bracing DivisionWARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively […]Read More
0 NASDAQ Companies - January 10, 2025Volcon MN1 Unit Arrives at Cycle Plaza Corpus Christi, Ready to SellAUSTIN, Texas, Jan. 10, 2025 (GLOBE NEWSWIRE) — Volcon ePowersports (NASDAQ: VLCN) is proud to announce that the Volcon MN1 […]Read More
0 NASDAQ Companies - January 10, 2025scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial ResultsPreliminary unaudited fourth quarter 2024 net revenue expected to be approximately $12 million to $12.3 million, representing 99% growth over […]Read More
0 NASDAQ Companies - January 10, 2025Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates– Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of […]Read More